Background:
Abnormalities in body composition are common in patients with hepatocellular carcinoma (HCC); however, their impact across different treatment modalities remains poorly understood. We systematically reviewed the prognostic value of body composition in patients with HCC, stratified by curative, locoregional...
Elisa Pinto, B. Barberio, M. Gambato et al.· Hepatology Communications· 0 citations
A practical, physiology-anchored approach that maximises enteral autonomy and quality of life while preventing the metabolic, hepatic and catheter-related complications of long-term intravenous feeding is proposed.
B. Barberio, Beatrice Varotto, Matteo D'Angelo et al.· Nutrients· 0 citations
Esophageal Cancer: Other
Esophageal achalasia is a rare motility disorder associated with an increased risk of esophageal squamous cell carcinoma (ESCC), with reported prevalence ranging from 0.4% to 9.2%. The risk is particularly elevated in end-stage disease, characterized by longstanding stasis and sigm...
F. Forattini, R. Salvador, B. Barberio et al.· Diseases of the esophagus· 0 citations
Serum miRNAs offer novel predictive and concurrent biomarker signals during biologic induction in Crohn’s disease, providing information complementary to faecal calprotectin.
Luisa Bertin, Lara Giraldi, Camilla Cavagna et al.· Frontiers in Medicine· 0 citations
Upadacitinib was effective and well-tolerated in AT-experienced Crohn's disease, including patients with active EIMs, with induction benefit maintained through 6 months without novel safety signals.
B. Barberio, F. D'Amico, L. Laterza et al.· Alimentary Pharmacology and...· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.